Lupin rises on getting USFDA approval for Famotidine injection

Mumbai, May 14 (Udaipur Kiran): Lupin is currently trading at Rs. 2248.35, up by 32.90 points or 1.49% from its previous closing of Rs. 2215.45 on the BSE. The scrip opened at Rs. 2253.85 and has touched a high and low of Rs. 2,255.45 and Rs. 2,240.00 respectively. So far 284 shares were traded on […]

Read More

Lupin Gains After Receiving USFDA EIR for Sambhajinagar Facility | Udaipur Kiran

Mumbai, 13 November (Udaipur Kiran)। Shares of Lupin edged higher on Thursday after the company announced it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Chhatrapati Sambhajinagar (Aurangabad) facility. The EIR follows a product-specific Pre-Approval Inspection (PAI) conducted by the USFDA between September 1–5, 2025. Lupin’s […]

Read More